about
Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhoodProbiotics for treating eczemaOverview of Reviews The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews.Hwangryunhaedoktang in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, two-centre trial--study protocolIntravenous immunoglobulin therapy for the treatment of severe atopic dermatitis.Eczema, sleep, and behavior in children.Pharmacoeconomics of drug therapy for atopic dermatitis.The cost of atopic dermatitis in the Netherlands: an international comparison.Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trialA framework for measuring costs to society of IgE-mediated food allergy.The socioeconomic impact of atopic dermatitis in the United States: a systematic review.Awareness of Atopic Dermatitis and Attitudes toward Different Types of Medical Institutions for Its Treatment among Adult Patients and the Parents of Pediatric Patients: A Survey of 500 Participants.Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses.Cumulative life damage in dermatologyUse of emollients in atopic dermatitis.Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial.Short-term growth and bone turnover in children undergoing occlusive steroid ('Wet-Wrap') dressings for treatment of atopic eczema.A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.SPINK5: a gene for atopic dermatitis and asthma.Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study.Concerns and expectations of parents with atopic infants.Pediatric atopic eczema: the impact of an educational intervention.
P2860
Q24186353-09C6CE47-B3EF-44B9-9C30-1B308AAF2EBAQ24241429-8D0F2C66-6614-474C-B124-4541F8CC18C9Q30521278-33D8B8FE-C0FC-40F8-8A36-DE8E8785EAB0Q34001192-262A43F3-80AD-4157-995C-F92F31E4E803Q34240736-C360C752-7218-41BC-A2C8-BD6C793DE6B2Q34458251-F4DDE4B1-696D-4D74-BBE2-F4605F31B245Q34544712-6AE80901-588B-47C1-8CEB-85AED600838DQ34941277-1A8A7667-3863-4C96-90FA-CBA4A2FA5022Q35715961-4DEDFBCE-B3FA-44C8-A00D-D30F760EBA11Q36169765-5C3E7466-937C-4E6B-A775-E781901395DFQ37096167-97F73BB5-3819-4B61-B3DA-94FF4937CAA8Q37446817-F8DA9E90-CFE8-4F3C-818A-8AF0F62497DBQ37970554-6E158274-F7C7-4610-8C87-03EF64A5DC78Q38266895-FD646584-9DFE-4B08-9BA6-C295B635C130Q38274647-FBE09E95-528E-4293-9239-6DD86D4C57D9Q42139482-3C76ECEB-02F8-4836-B4C1-1ED9F40C746AQ44604973-5C206590-2F7A-41B9-A3F3-52F70BB1CBDBQ44628540-C6FBD373-1566-4D79-AC80-68B0B9BAECC5Q47988601-CEEC5CCB-1263-4824-B950-BEA5ADDC7A8BQ48515453-6E83631C-3A48-4E73-A560-1EBB6156849DQ48714383-B677C9A2-CEF8-404C-B4C6-DF551B403493Q53224223-1CB8EC81-FE04-4D78-AA31-0DC263F22C64
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Atopic eczema: its social and financial costs.
@en
Atopic eczema: its social and financial costs.
@nl
type
label
Atopic eczema: its social and financial costs.
@en
Atopic eczema: its social and financial costs.
@nl
prefLabel
Atopic eczema: its social and financial costs.
@en
Atopic eczema: its social and financial costs.
@nl
P1476
Atopic eczema: its social and financial costs.
@en
P2093
P304
P356
10.1046/J.1440-1754.1999.00343.X
P577
1999-06-01T00:00:00Z